Published in Gene Therapy Weekly, February 26th, 1996
The U.S. patent, number 5,399,346, was issued on March 21, 1995, and lists as Inventors Drs. W. French Anderson, Michael Blaese, and Steven Rosenberg. When issued, its claims were widely interpreted as encompassing the entire field of ex vivo gene therapy.
The Somatix application involved in the interference is derived from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.